Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 6/2010

01-12-2010

Preventing Poor Psychological and Health Outcomes in Pediatric Type 1 Diabetes

Authors: Naomi R. Fogel, Jill Weissberg-Benchell

Published in: Current Diabetes Reports | Issue 6/2010

Login to get access

Abstract

Youth with type 1 diabetes are at high risk for psychosocial morbidities. These include depression, disturbed eating behavior, family conflict, poor health-related quality of life, low self-efficacy, and difficulty with medical adherence and metabolic control. A number of prevention interventions have been studied in this group, with the overall goal of improving adaptation and coping skills. This paper reviews the current research aimed at preventing poor outcomes in youth with type 1 diabetes and recommends simple interventions that can be added to clinical encounters. Recommendations for future psychosocial prevention studies are also discussed.
Literature
1.
Institute of Medicine: The Future of the Public’s Health in the 21st Century. Washington D.C.: National Academy Press; 2002.
2.
Evans D, Seligman M: Introduction In Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don’t Know. Edited by Evans D, Foa E, Gur R, Hendin H, O’Brien C, Seligman M, Walsh T. Oxford: Oxford University Press; 2005:xxv–xi.CrossRef
3.
Northam E, Matthews L, Anderson P, et al.: Psychiatric morbidity and health outcomes in type 1 diabetes: perspectives from a prospective longitudinal study. Diabet Med 2005, 22:152–157.CrossRefPubMed
4.
Hood K, Peterson C, Rohan J, Drotar D: Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics 2009, 124:1171–1179.CrossRef
5.
Wysocki T, Harris M, Buckloh L, et al.: Self care autonomy and outcomes of intensive therapy or usual care in youth with type 1 diabetes. J Pediatr Psychol 2006, 31:1036–1045.CrossRefPubMed
6.
Rewers A, Chase P, Mackenzie T, et al.: Predictors of acute complications in children with type 1 diabetes. JAMA 2002, 287:2511–2518.CrossRefPubMed
7.
Leonard B, Jang Y, Savik K, et al.: Psychosocial factors associated with metabolic control in youth with type 1 diabetes. J Pediatr Nurs 2002, 7:28–37.CrossRef
8.
Hassan K, Loar R, Anderson B, Heptuall R: The role of socioeconomic status, depression, quality of life and glycemic control in type 1 diabetes mellitus. J Pediatr 2006, 149:526–531.CrossRefPubMed
9.
Bryden KS, Dunger DB, Mayou RA, et al.: Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care 2003, 26:1052–1057.CrossRefPubMed
10.
Cohen D, Lumley M, Naar-King S, et al.: Child behavior problems and family functioning as predictors of adherence and glycemic control in economically disadvantaged children with type 1 diabetes. J Pediatr Psychol 2004, 29:171–184.CrossRefPubMed
11.
Hoey H, Aastoot H, Chiarelli F, et al.: Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care 2001, 24:1923–1928.CrossRefPubMed
12.
Stewart S, Rao U, Emslie G, et al.: Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics 2005, 115:1315–1319.CrossRefPubMed
13.
Seiffge-Krenke I, Stemmler M: Coping with everyday stress and links to medical and psychosocial adaptation in diabetic adolescents. J Adolesc Health 2003, 33:180–188.CrossRefPubMed
14.
Svoren B, Butler D, Levine B, et al.: Reducing acute adverse outcomes in youth with type 1 diabetes: a randomized control trial. Pediatrics 2003, 112: 914–922.CrossRefPubMed
15.
Grey M, Whittemore R, Tamborlane W: Depression in type 1 diabetes in children: natural history and correlates. J Psychosom Res 2002, 53:907–911.CrossRefPubMed
16.
Hood K, Huestis S, Maher A, et al.: Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 2006, 29:1389–1391.CrossRefPubMed
17.
McGrady M, Laffel L, Drotar D, et al.: Depressive symptoms and glycemic control in adolescents with type 1 diabetes: mediational role of blood glucose monitoring. Diabetes Care 2009, 32:804–806.CrossRefPubMed
18.
Costello E, Mustillo S, Erkanli A, et al.: Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003, 60:837–844.CrossRefPubMed
19.
Helgeson V, Siminerio L, Escobar O, Becker D: Predictors of metabolic control among adolescents with diabetes: a four year longitudinal study. J Pediatr Psychol 2009, 34:254–270.CrossRefPubMed
20.
Lawrence J, Standiford D, Loots B: Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth Study. Pediatrics 2006, 117:1348–1358.CrossRefPubMed
21.
Glasgow AM, Weissberg-Benchell JA, Tynan WD, et al.: Readmissions of children with diabetes mellitus to a children’s hospital. Pediatrics 1991, 88:98–104.PubMed
22.
Garrison M, Katon W, Richardson L: The impact of psychiatric comorbidities on readmissions for diabetes in youth. Diabetes Care 2005, 28:2150–2154.CrossRefPubMed
23.
Duke D, Geffken G, Lewin A, et al.: Glycemic control in youth with type 1 diabetes: family predictors and mediators. J Pediatr Psychol 2008, 33:719–727.CrossRefPubMed
24.
Jones JM, Lawson ML, Daneman D, et al.: Eating disorders in adolescent females with and without type 1 diabetes: cross-sectional study. BMJ 2000, 320:1563–1566.CrossRefPubMed
25.
Peveler RC, Bryden KS, Neil AW, et al.: The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes. Diabetes Care 2005, 28:84–88.CrossRefPubMed
26.
Olmsted MP, Colton PA, Daneman, D, et al.: Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care 2008, 31:1978–1982.CrossRefPubMed
27.
Stice E, Marti CN, Shaw H, Jaconis M: An 8-year longitudinal study of the natural history of threshold, subthreshold, and partial eating disorders from a community sample of adolescents. J Abnorm Psychol 2009, 18:587–597.CrossRef
28.
Gadalla T, Piran N: Psychiatric comorbidity in women with disordered eating behavior: a national study. Women Health 2008, 48:467–484.CrossRefPubMed
29.
Rydall AC, Rodin GM, Olmsted MP, et al.: Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997, 336:1849–1854.CrossRefPubMed
30.
Goebel-Fabbri AE, Fikkan J, Franko DL, et al.: Insulin restriction and associated morbidity and motality in women with type 1 diabetes. Diabetes Care 2008, 31:415–419.CrossRefPubMed
31.
Olmsted MP, Daneman D, Rydall AC, et al.: The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord 2002, 32:230–239.CrossRefPubMed
32.
Stice E, Shaw H, Marti N: A meta-analytic review of eating disorder prevention programs: encouraging findings. Annu Rev Clin Psychol 2007, 3:207–231.CrossRefPubMed
33.
Anderson B, Vangness L, Connell A, et al.: Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes. Diabet Med 2002, 19:635–642.CrossRefPubMed
34.
Ellis D, Templin TN, Naar-King S, Frey MA: Toward conceptual clarity in a critical parenting construct: parental monitoring in youth with chronic illness. J Pediatr Psychol 2008, 33:799–808.CrossRefPubMed
35.
Weibe D, Berg CA, Korbel C, et al.: Children’s appraisals of maternal involvement in coping with diabetes: enhancing our understanding of adherence, metabolic control, and quality of life across adolescence. J Pediatr Psychol 2005, 30:167–178.CrossRef
36.
Wysocki T, Nansel T, Holmbeck G, et al.: Collaborative involvement of primary and secondary caregivers: associations with youth’s diabetes outcomes. J Pediatr Psychol 2009, 34:869–881.CrossRefPubMed
37.
Weissberg-Benchell J, Nansel T, Holmbeck G, et al.: Generic versus diabetes-specific quality of life and parent-child behaviors among youth with type 1 diabetes. J Pediatr Psychol 2009, 34:977–988.CrossRefPubMed
38.
Nansel T, Rovner A, Haynie D, et al.: Development and validation of the collaborative parent involvement scale for youth with type 1 diabetes. J Pediatr Psychol 2009, 34:30–40.CrossRefPubMed
39.
Anderson B, Brackett J, Ho J, Laffel L: An office-based intervention to maintain parent-adolescent teamwork in diabetes management: impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care 1999, 22:713–721.CrossRefPubMed
40.
Laffel LM, Vangsness L, Connell A, et al.: Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003, 142:409–416.CrossRefPubMed
41.
Spieth LE, Harris CV: Assessment of health-related quality of life in children and adolescents: an integrative review. J Pediatr Psychol 1996, 21:175–193.CrossRefPubMed
42.
Cella D: Quality of life outcomes: measurement and validation. Oncology (Williston Park) 1996, 10(11 Suppl):233–246
43.
Varni JW, Seid M, Kurtin PS: PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001, 39:800–812.CrossRefPubMed
44.
Seid M, Varni JW, Rode CA, Katz ER: The Pediatric Cancer Quality of Life Inventory: a modular approach to measuring health-related quality of life in children with cancer. Int J Cancer Suppl 1999, 12:71–76.CrossRefPubMed
45.
Silverstein J, Klingensmith G, Copeland K, et al.: Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005, 28:186–212.CrossRefPubMed
46.
• de Wit M, Delemarre-van de Waal H, Bokma JA, et al.: Monitoring and discussing health-related quality of life in adolescents with type 1 diabetes improve psychosocial well-being: a randomized controlled trial. Diabetes Care 2008, 31:1521–1526. HRQoL in adolescents was assessed during clinic visits and then discussed with the medical team. At 1-year follow-up, teens showed fewer behavioral problems, improved self-esteem, more participation in family activities, and were more satisfied with their medical care.
47.
de Wit M, Delemarre-van de Waal H, Bokma JA, et al.: Follow-up results on monitoring and discussing health-related quality of life in adolescent diabetes care: benefits do not sustain in routine practice. Pediatr Diabetes 2010, 11:175–181.CrossRefPubMed
48.
Graue M, Wentzel-Larsen T, Hanestad BR, Sovik O: Evaluation of a programme of group visits and computer-assisted consultations in the treatment of adolescents with type 1 diabetes. Diabet Med 2005, 22:1522–1529.CrossRefPubMed
49.
• Channon SJ, Huws-Thomas MV, Rollnick S, et al.: A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 2007, 30:1390–1395. Teens participating in a motivational interviewing intervention showed lower HbA 1c levels at the end of the 12-month intervention, and this was maintained for 1 year afterward. In addition, the intervention group had improved life satisfaction, lower life worry, less anxiety, and increased positive well-being. After the 12-month follow-up period, many of these differences persisted.
50.
51.
Davidson M, Boland EA, Grey M: Teaching teens to cope: coping skills training for adolescents with insulin-dependent diabetes mellitus. J Soc Pediatr Nurs 1997, 2:65–72.CrossRefPubMed
52.
Grey M, Boland EA, Davidson M, et al.: Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr 2000, 137:107–113.CrossRefPubMed
53.
• Grey M, Whittemore R, Jaser S, et al.: Effects of coping skills training in school-age children with type 1 diabetes. Res Nurs Health 2009, 32:405–418. CST was offered in six weekly sessions to a group of 8- to 12-year-old children with type 1 diabetes and their parents. This study is especially important because it looks at school-age children, whereas most type 1 diabetes prevention studies enroll adolescents, and because it also included parents. This study suggests that family-based group programs are feasible and important for long-term adaptation and coping.
54.
Franklin VL, Waller A, Pagliari C, Greene SA: A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006, 23:1332–1338.CrossRefPubMed
55.
Howells L, Wilson AC, Skinner TC, et al.: A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with type 1 diabetes. Diabet Med 2002, 19:643–648.CrossRefPubMed
56.
Galatzer A, Amir S, Gil R, et al.: Crisis intervention program in newly diagnosed diabetic children. Diabetes Care 1982, 5:414–419.CrossRefPubMed
57.
Hains AA, Berlin KS, Davies WH, et al.: Attributions of adolescents with type 1 diabetes related to performing diabetes care around friends and peers: the moderating role of friend support. J Pediatr Psychol 2007, 32:561–570.CrossRefPubMed
58.
Greco P, Pendley JS, McDonell K, Reeves G: A peer group intervention for adolescents with type 1 diabetes and their best friends. J Pediatr Psychol 2001, 26:485–490.CrossRefPubMed
59.
American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596–615.CrossRef
Metadata
Title
Preventing Poor Psychological and Health Outcomes in Pediatric Type 1 Diabetes
Authors
Naomi R. Fogel
Jill Weissberg-Benchell
Publication date
01-12-2010
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 6/2010
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-010-0145-z

Other articles of this Issue 6/2010

Current Diabetes Reports 6/2010 Go to the issue

ReviewPaper

Genetics of Diabetes Complications

Clinical Trial Report

Preconception Counseling for Adolescent Females with Type 1 Diabetes: The READY-Girls Program

ReviewPaper

Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes

ReviewPaper

Getting (the Most) Out of the Research Business: Interventions for Youth with T1DM

ReviewPaper

Biological Basis of Depression in Adults with Diabetes

ReviewPaper

From Genetic Association to Molecular Mechanism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits